Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2023 Earnings

7AugExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-13
-8.74
-4.47
-0.21

Details

Expected EPS
-0.68
Actual EPS
-1.64
Surprise EPS
-0.96
Surprise Percent
+141.18%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -1.64 per share for Q2 2023.

0 Comments

Share your thoughts